Shukra Pharmaceuticals Wins 211.59 Crore Contract from Rajasthan Medical Services Corporation Limited

Shukra Pharmaceuticals Limited has received a Letter of Acceptance from Rajasthan Medical Services Corporation Limited (RMSCL) for a Rate Contract cum Supply Agreement. The Company has been awarded a contract worth 211.59 Crore for the supply of essential pharmaceutical formulations to government health institutions across Rajasthan. The supplies are scheduled to be completed by December 2026. This contract reinforces Shukra Pharmaceuticals’ reputation as a trusted healthcare partner in the public sector and reflects the Company’s growing capabilities in large-scale institutional supply. The Company is currently finalizing the required formalities, including execution of the agreement and submission of the stipulated performance security. This achievement is expected to significantly enhance the Company's visibility in the institutional segment and contribute meaningfully to the revenue pipeline over the coming quarters.